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In a previous communication (1) the authors reported on the effect of an oral androgen (9 fluoro-11B-hydroxy-17 methyltestosterone, Halotestin) 'on the memory function of 13 residents of an old peoples home (mean age 80.7 y:ears). This group was compared with a matched control group drawn from the same population. Halotestin produ~ed in the experimental subjects a feelinõ f well-being, increased purposeful activity and appetite and also had some sedative effect. No significant differences could be found in the total memory scores of the experimental group before and after treatment nor were these scores significantly different from the total memory scores of the control group after the same observation period. However, significant differences were found between the experimental and the control group on two subtests of the memory scale. The experimental group improved on recall of logical and meaningful material whereas the control group lost on the same subtest and the difference between the scores of the two groups proved statistically significant. On the subtest of recall (after an unrelated question) of visually presented material the experimental group had lower scores after treatment whereas the control group had gained after the same period of time. This difference also proved statistically significant.
The study also confirmed previous findings (2) that there exists a statistically very significant difference in~he memory scores between those aged Individuals who clinically show a senile amnestic syndrome, as compared with those who have only a "mild" senescent memory impairment as defined previously. It is interesting to note that the significant differences observed after Halotestin treatment on the two subtests mentioned occurred only in the subjects with the "mild" type of senescent memory dysfunction whereas the subjects with an amnestic syndrome did not show statistically significant changes due to treatment.
These results were interpreted to mean that androgen treatment in the dosage applied tended to increase perceptual alertness as well as interest and motivation, thus leading to improved recall of logical and meaningful material whereas the same factor namely the increased interest in the environment including the investigator and the intervening question might well have interfered with the recall of visually presented objects.
As this effect on memory function had been obtained with a relatively small dosage of Halotestin (5 m&,) giveI1; ov~r a relatively short observation penod It was found interesting to see whether these results could be maintained or even improved when the same drug were given to the same subjects over a longer period of time and in a higher dosage, as well as higher dosages to another experimental group. It is the purp?se of this paper to report on these studies,
Material and Method
The first series of observations relates to the same group of subjects as previously reported. These subjects continued to receive a daily dosage of 5 mg Halotestin for a period of 6 months, after which time the dosage was increased to 10 mg daily for another 3 months. Each subject therefore received an average of 1800 mg. of Halotestin, the total observation period covering 9 months. During this time four subjects, two of the experimental and two. of the control group died. In the expenmental group two more subjects had to be excluded because of physical disease which rendered them unable to cooperate with the tests, and the same applied to one subject in the control group.
This part of our report, therefore, is based on an experimental group composed of 9 subjects, 2 men and 7 women, and a control group comprising 10 subjects, 3 men and 7 women. As regards the type of memory impairment present in these subjects, the experimental group comprised 6 subjects with the "mild" type of memory defect and 3 with a senile amnestic syndrome, whereas the control group comprised 5 subjects with "mild" memory defect and 5 with an amnestic syndrome.
As mentioned in our previous communication, all experimental and control subjects were continued on Vitamin B medication which they had been receiving prior to the experiment. Some of our subjects also received Chlorpromazine and night sedation when indicated. No placebo tablets were given to the control subjects in this series.
Memory function was tested by means of a Memory Testing Scale described earlier (1) . The tests were repeated at regular intervals averaging 3-4 months.
Results
The beneficial effect of Halotestin on the experimental subjects continued throughout the observation period but became less noticeable as time went on. We did not observe any case of jaundice or edema in our experimental group, nor was there any clinical indication of tumour growth. The fatalities mentioned above occurred in both groups with equal frequency and were due to cerebrovascular accidents and pneumonia. Table I shows that the control group as well as the experimental group had suffered a loss in their total memory scores at the end of the nine months observation period. This loss proved not significant on statistical analysis using Student's test as well as analysis of variance. There was, however, a statistically significant loss in the total me-mory scores of the experimental group at the end of the nine months period as compared with the scores achieved at the end of 6 months of observation (0.05>P>0.02).
Statistical analysis of the scores achieved by the subjects of both groups on the eight subtests at the beginning of the experiment, at the end of six months and at the end of the nine months periods did not reveal significant differences in either group in the subtests of "Orientation", "Recent Memory" and "Digit Span" between the scores achieved at the three testing periods. Statistically significant differences, however, were found on the following subtests: "Current information", "Partial memory", "Remote memory", "Recall of logical and meaningful material" and "Five object test". On the subtest for "Remote memory" both the control group as well as the experimental group showed a statistically significant loss between the scores at the end of the nine months observation period as compared with the scores at the end of six months, (0.05>P>0.02) and (P<O.OOl) respectively, but no significant differences as compared with the scores at the beginning of the observation period.
On the remaining four subtests statistically significant differences were found only in the experimental group: On the subtests f.or "Current information" and "Partial memory" the scores of this group at the end of the nine months period were significantly lower than at the end of the six months period (0.05 > P>O.02). On the subtest of "Recall of logical and meaningful material" the scores at the end of the nine months observation period tended to be significantly lower than at the end of six months (0.IO>P>0.05) whereas the scores reached at the beginning and at the end of the experiment were not significantly different. Finally in the "Five objects" subtest the scores of the experimental group at the end of the nine months were significantly lower 
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The number in the bracket gives the number of subjects for which the adjacent mean and standard error were calculated.
than at the beginning of the experiment (0.02>P>0.01). An analysis of variance was carried out with regard to the type of memory impairment, the groups and the duration of treatment. This analysis again confirmed the previously found difference between the test scores of the subjects with the "mild" type of memory impairment as compared with the subjects suffering from an amnestic syndrome, as highly significant (P<O.OOI). This applied to the total scores as well as to all individual subtests in both the experimental and the control group bebfore and after treatment.
There were, however, no significant differences in either group due to time or to treatment with the exception of one subtest, the "Five object test", where the experimental group showedsignificantly lower scores after 3 months of treatment (0.05>P>0.02) as compared with the pretreatment scores. This difference persisted when Halotestin was given for another 3 months in the same dosage and then again when for the last 3 months the Halotestin dosage was increased to 10 mg. daily.
These results can best be summarized by stating that the total memory scores of both groups did not signifi-cantly change over a nine months observation period. The experimental group, how-ever, showed a significant decline of the total memory scores at the end of the nine months period as compared with the end of the six months period.
The same pattern appeared in the subtest of "Recall of logical and meaningful material", where the scores achieved by the experimental group at the end of nine months were not significantly different from those at the beginning of the experiment but tended to be significantly lower when compared with the scores at the end of the 6 months period. In the "Five object" subtest there was a significant loss of scores of the experimental subjects in all 3 test periods.
After the experiment just described was completed another series was started whereby each of the experimental subjects received 20 mg Halotestin per day in form of four 5 mg. tablets for a five and a half months observation period. The control group received 4 placebo tablets of the same size, shape and colour daily over the same period of time. The experimental group 'comprised 19 subjects, 8 men and 11 women, with an age range of 72-89 years and a mean age of 81.5 years. The control group was composed of 20 subj ects (6 men and 14 women) with an age range of 71-97 years and a mean age of 82.2 years. There was no statistically significant difference between the two groups due to age. The number in the bracket gives the number of subjects for which the adjacent mean and standard error were calculated.
The experimental group comprised 15 subjects with the "mild" type of memory impairment and 4 with a senile amnestic syndrome, whereas in the control group 18 subjects showed the "mild" and two the amnestic syndrome type of memory impairment. The greater number of individuals with the "mild" type of memory dysfunction in both groups was chosen because the preliminary study had shown that the Halotestin effect was particularly noticeable in subjects with this type of memory impairment.
It should be mentioned that even with this increased dosage of Halotestin no untoward side effects were noted; no case of jaundice occurred, nor was there any case of heart failure or edema formation. The experimental subjects of this series also reported a general feeling of well-being, showed an increase in purposeful activity and we could also observe the mild sedative effect noted previously, particularly during the first few months of the experiment. Table II gives a survey of the total memory scores of both the control and the experimental group at the beginning and at the end of the observation period. Both groups as a whole showed a loss in total memory scores, and the same applied to the subgroups with "mild" memory deficit and the subgroup with an amnestic syndrome of the experimen-tal group. Only the subgroup with an amnestic syndrome of the controls showed a slight gain.
Statistical evaluation was again carried out by means of Student's test and analysis of variance. It confirmed the previous finding that the memory scores of the subjects with a senile amnestic syndrome were significantly lower than the scores of the subjects with the "mild" memory dysfunction. This was true for the control as well as for the experimental group both at the beginning and at the end of the observation period (P<0.001).
The decline in total memory scores in both groups after the five and a half months observation period was statistically not significant, nor was a significant difference found between the "retest minus test" scores of the control group as compared to the experimental group.
As regards the individual subtests, significant differences between the retest values at the termination of the observation period and the test scores at its onset were found in subtest "Orientation" where both the control and the experimental group scored significantly less at the end of the observation period, (control group 0.02>P>O.01, experimental group O.OI>P>O.OOI). On subtest "Partial memory" only the controls had significantly lower retest scores (0.05 > P>0.02), whereas the retest scores of the experimental subjects were not significantly different from their test scores, and the same applied to the subtest "Digit spann". The significant differences were again found only in the scores of the subjects with the "mild" type of memory deficit.
In the analysis of variance the presence of interaction between treatment time and group was tested for. There were no significant interaction or significant differences found with this form of statistical analysis as regards the total scores. As regards the individual subtests the following results were obtained.
On the subtest "Recall of logical and meaningful material" there was a significant F value for treatment (0.025>P> 0.01). The mean for the experimental group was significantly higher than that of the control group. A difference in the same direction, but only of borderline significance, was apparent before treatment. Therefore, this difference was probably not due to treatment alone. On the subtest "Digit span" the mean of the experimental group (6.4) tended to be higher than the control mean (5.7). There was a borderline F value for treatment (0.1O>P>0.05). This difference was due chiefly to a drop in the scores of the control group during the retest period. This fall did not occur in the experimental group. Treatment with Halotestin therefore, tended to prevent a decline in this subtest. On the same subtest the retest mean was significantly lower than the test mean (0.025>P>0.01) which again was due chiefly to the decline of the retest values of the control group. On the subtest "Five objects" the retest mean tended to be lower than the test mean but the difference was of only borderline significance (0.1O>P>0.05). This was due to lower scores in both the control and the experimental groups during the retest period.
Summarizing the results of this experiment it would appear that the total memory scores in both groups did not significantly change over a five and a half months observation period. Both groups showed a significant loss of scores on the subtest "Orientation" whereas on the subtests "Partial memory" and "Digit span" only the control but not the experimental subjects showed significant losses. As regards the subtests "Recall of logical and meaningful material" the experimental group showed a higher score mean after treatment than at its onset, whereas on the subtest "Five objects" both groups scored less at the end of our observation than at its onset. Again all significant differences were due to the scores achieved by the subjects with the "mild" type of memory impairment.
Discussion
It was suggested in our previous communication that further investigation of the androgen effect on senescent memory function should be undertaken with varying dosage and varying duration of treatment and also with attempts to control more of the environmental variables. This study represents such an undertaking.
In the first experiment reported here the same subjects were used as in our previous study. The duration of the Halotestin medication was extended to six months at the previous dosage of 5 mg daily. The medication was then increased to 10 mg for another three months thus extending the total observation period to 9 months with a total dosage of 1800 mg of Halotestin for every individual subject. No other environmental control was used in this series than mentioned previously, namely that care was taken that the subjects on Halotestin did not become aware of receiving special medication or more attention than the control subjects. In the second experiment reported here another control measure was introduced, namely the use of placebo tablets which were given to the control subjects at the same time and in the same number as the Halotestin tablets to the experimen-350 CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL Vol. 6, No.6 tal subjects. In this second series the Halotestin medication was increased to 20 mg daily which, for the 5 Yz months observation period, amounted to about 3300 mg for each subject.
Our observation showed that the general beneficial effect produced by Halotestin in the experimental subjects during the first months of the observation period slowly faded as time went on and completely ceased when Halotestin was discontinued.
As regards memory function this study again confirmed that there exists a statistically highly significant quantitative difference between the qualitatively different "mild" type of senescent memory dysfunction and the senile amnestic syndrome. Halotestin treatment did not change the type of memory dysfunction present in our experimental subjects. It is noteworthy in this connection that whatever significant changes could be observed occurred only in the group of subjects with the "mild" type of memory impairment but not in those with a senile amnestic syndrome. These facts seem to be in keeping with the assumption that the "mild" and the "amnestic syndrome" type of senescent memory decline represent psychopathologically and pathophysiologically different processes.
In neither experiment did the total memory scores significantly change over the observation periods of nine and five and one half months respectively. As this was found true for the experimental groups as well as for the control groups it seems safe to assume that, cerebrovascular accidents excluded senescent memory decline is a slow process regardless of the type of memory impairment present. Furthermore, our observation shows that Halotestin at least in the dosage and for the time used in our experiments did not improve the total memory scores of the experimental groups. The fact, however, that in the first experiment the total scores of the experimental group after 9 months of treatment were significantly lower than after 6 months but not significantly different from the scores at the beginning of the experiment seems to indicate the possibility that Halotestin did produce some improvement in the total memory scores during the first part of that experiment which may not have been noted.
Turning now to the individual subtests in the first experiment, we find in 3 of them a pattern similar to that observed with the total memory scores. This applies to the subtests "Current information", "Remote memory" and "Partial memory". The experimental group showed at the end of nine months significantly lower scores than at the 6 months test period, but no significant change as compared to the onset of the experiment. The explanation for this interesting finding may be the same as that offered for the total scores.
There were, however, two noteworthy exceptions to these subtest results. On the subtest "Recall of logical and meaningful material" the experimental group showed at the end of 9 months scores which only tended to be lower than the scores at the end of six months and on the "Five objects" subtest the test scores of the experimental group at the end of the experiment were significantly lower than the scores at the beginning of the experiment and also than those at the end of the six months period. It may be remembered that it was on these subtests where the experimental subjects of our preliminary study showed significant changes: improvement of scores on the subtest "Recall of logical and meaningful material" and loss of scores on the "Five objects test". It would seem therefore that prolonging the experiment for another six months and increasing the Halotestin dosage from 5 to 10 mg per day for the last 3 months of the experiment prevented the scores on the subtest "Recall of logical and meaningful material" (where there had been a significant improvement at the 3 months level) from declining to the same extent as the scores on the other subtests. On the "Five Objects" subtest on the other hand where there had been a significant decline of scores at the end of 3 months this decline continued to a significant extent throughout the experiment.
In the second experiment the experimental subjects received 20 mg of Halotestin daily over a 5Yz months period, whereas the control subjects were given placebo tablets. In most of the subtests, only the controls showed statistically significant losses with the exception of the subtest "Orientation" and the "Five objects test" where both the experimental and the control group showed lower means at the end of the experiment than at its beginning. On the subtest "Recall of logical and meaningful material", however, the Halotestin group showed a significantly higher mean after treatment than at its onset.
In our pervious communication we expressed the view that the improvement in "Recall of logical and meaningful material" observed in our experimental subjects was due to an increase in perceptual alertness, interest and motivation produced by the androgen and possibly connected with its anabolic effect, and that the same factor was responsible for the decrease in scores on the "Five objects test." The results observed in the present experiments seem to confirm this view. It was mentioned above that the general beneficial effect, the feeling of well being and increased activity which we could observe in our experimental subjects during the first weeks of observation slowly decreased as time went on. It seems that the decline in memory function after a peak was reached parallels the slow decline of this general beneficial effect. The theoretical implications of such an assumption have already been discussed in our previous communication. Suffice it to say that on the basis of the present experiments further studies on the effect of androgen and other hormones on memory function seem to be warranted particularly in the hope that a further decline in memory function in individuals showing the beginning of the "mild" type of senescent memory dysfunction might be prevented. Our study seems to indicate that after a certain period of time an adaptation of the organism to the general psychological effect of the androgen as well as to its effect on memory function takes place regardless of the dosage applied. Caldwell and coworkers (3, 4) have expressed similar ideas regarding the psychological effect of estradiol on aged women. This seems to suggest that the intermittent application of medium dosages over shorter periods of time might 'be more beneficial to the aging person than the longterm application of high dosages. Another possibility would be the use of other sex hormones. Studies are in progress to investigate the effect of such a procedure on memory function.
Summary
On oral androgen (9 fiuoro-Ll Bvhydroxy-17 methyltestosterone) had been found to improve recall of logical and meaningful material in 13 senescent people, without raising their total memory scores. Prolonged administration of this substance to the same subjects in the same and a somewhat increased dosage did not improve the previously achieved results. The improvement in memory function paralleled the general beneficial effect which the androgen produced in the subjects. The same results were obtained with a still higher dosage in another group of experimental subjects. Some theoretical implications of these findings are discussed. adrninistre a un groupe de 13 patients souffrant de senescence. On a note chez eux une amelioration de leur memoire d'evocation pour des evenements passes qui leur etaient significatifs sans que pour cela on ait note une amelioration dans les tests sur leur mernoire globale.
L'administration prolongee de ladite substance au merne dosage ou rneme a un taux pluseleve n'a pas cependant augmente l'amelioration des resultats deja obtenus sur une periode de six mois. L'amelioration de la memoire est en fonction des benefices que les patients ont subis dans leur etat general grace a l'administration de cette substance.
Les memes resultats furent obtenus avec un autre groupe de sujets avec un dosage plus eleve, Quelques implications theoriques en relation avec l'administration de cet substance et de la mernoire sont discutees,
